In vertebrates, multipotent progenitors located in the pharyngeal mesoderm form cardiomyocytes and branchiomeric head muscles, but the dynamic gene expression programmes and mechanisms underlying cardiopharyngeal multipotency and heart versus head muscle fate choices remain elusive. Here, we used single-cell genomics in the simple chordate model Ciona to reconstruct developmental trajectories forming first and second heart lineages and pharyngeal muscle precursors and characterize the molecular underpinnings of cardiopharyngeal fate choices. We show that FGF-MAPK signalling maintains multipotency and promotes the pharyngeal muscle fate, whereas signal termination permits the deployment of a pan-cardiac programme, shared by the first and second heart lineages, to define heart identity. In the second heart lineage, a Tbx1/10-Dach pathway actively suppresses the first heart lineage programme, conditioning later cell diversity in the beating heart. Finally, cross-species comparisons between Ciona and the mouse evoke the deep evolutionary origins of cardiopharyngeal networks in chordates.
D
istinct cell types form multicellular animals and execute specialized functions within defined organs and systems, implying that individual cells within progenitor fields must acquire both organ-level and cell-type-specific identities. The mammalian heart comprises chamber-specific cardiomyocytes, various endocardial cell types, fibroblasts and smooth muscles 1 , and despite their specialized features these cells share a cardiac identity. Popular models posit that heart cells emerge from multipotent cardiovascular progenitors, implying that multipotent progenitors are first imbued with a cardiac identity, before producing a diversity of cell types. Consistent with this model, mammalian heart cells emerge primarily from Mesp1 + mesodermal progenitors [2] [3] [4] . However, lineage tracing and clonal analyses have indicated that distinct compartments arise from separate progenitor pools, referred to as the first and second heart fields [5] [6] [7] [8] . In addition, most early cardiac progenitors produce only one cell type 3 , and cell-type segregation occurs early, possibly before commitment to a heart identity 9 . Moreover, derivatives of the second heart field (for example cardiomyocytes of the right ventricle and outflow tract) share a common origin with branchiomeric head muscles, in the cardiopharyngeal mesoderm 3, [10] [11] [12] [13] [14] [15] [16] . The characteristics of multipotent cardiopharyngeal progenitors, and the mechanisms underlying early heart versus pharyngeal/ branchiomeric muscle fate choices, remain largely elusive, and studies are partially hindered by the complexity of vertebrate embryos 16 . The tunicate Ciona has emerged as an innovative chordate model to study cardiopharyngeal development with unprecedented spatiotemporal resolution. In Ciona, invariant cell divisions produce distinct first and second heart lineages, and pharyngeal muscle precursors, from defined multipotent cardiopharyngeal progenitors 17, 18 ( Fig. 1a) . Multipotent progenitors exhibit multilineage transcriptional priming, whereby conserved fate-specific determinants are transiently co-expressed, before regulatory cross-antagonisms partition the heart and pharyngeal muscle programmes to their corresponding fate-restricted precursors [17] [18] [19] . Here we characterize, with single-cell resolution, the genome-wide characteristics and regulatory mechanisms governing cardiopharyngeal multipotency, early fate choices, and the establishment of cell diversity in the beating heart.
Results
Single-cell transcriptome profiling of early cardiopharyngeal lineages. To characterize gene expression changes underlying the transitions from multipotent progenitors to distinct fate-restricted precursors, we performed plate-based single-cell RNA sequencing (scRNA-seq) with Smart-seq2 (ref. 20 ) on cardiopharyngeal-lineage cells that had been purified by fluorescence-activated cell sorting (FACS) from synchronously developing embryos and larvae (Fig. 1a) . We obtained 848 high-quality single-cell transcriptomes at five time points covering early cardiopharyngeal development ( Fig. 1a and Supplementary Fig. 1a ). Using an unsupervised strategy 21 , we clustered single-cell transcriptomes from each time, and identified clusters according to known markers and previously established lineage information ( Fig. 1b and Supplementary Fig. 1b,c) . Focusing on fate-restricted cells isolated from post-hatching larvae (18 and 20 hours post-fertilization (hpf), FABA stages 26-28; Supplementary Table 1) , we identified clusters of Gata4/5/6 + first and second heart precursors (FHPs and SHPs), and Ebf + atrial siphon muscle (ASM) precursors 18, 19, 22 ( Fig. 1b and Supplementary  Fig. 1c ). Differential expression analyses identified (1) ASM/pharyngeal muscle versus pan-cardiac-specific markers and (2) FHPversus SHP-specific markers ( Fig. 1c and Supplementary Table 2 ). The top 111 predicted pan-cardiac genes comprised established cardiac determinants, including Gata4/5/6, Nk4/Nkx2-5 and Hand, and we confirmed heart-specific expression by fluorescent in situ hybridization (FISH) for 19 candidate markers, including Meis and Lrp4/8 (Fig. 1d, Supplementary Fig. 2a and Supplementary Tables 2  and 3 ). The pan-cardiac versus pharyngeal muscle contrast dominated late cellular heterogeneity, but FHP and SHP populations also segregated ( Fig. 1b and Supplementary Fig. 1c Fig. 1a ). Black lines, principal curves; light grey contours, single-cell density distributions. The colour coding corresponds to assigned cell identities following clustering at each time. DC, diffusion coordinate. c, Distribution of identified cell types isolated at defined times along the trajectories, showing the general agreement between the time series and developmental progression, but also that cells isolated at a given time are not all at the same developmental pseudotime. ). e, Heatmap of smoothed expression profiles for candidate ASM-specific Ebf target genes defined in ref. 4 , showing activation pseudotimes in regulatory states ASM2 and ASM3 (left, blue bars). White vertical lines mark transitions between indicated regulatory states. f, Predicted induction pseudotime of candidate ASM-specific Ebf target genes (black dashed lines separate corresponding ASM regulatory states). Regulatory state of activation pseudotime Tables 2 and 3 ). Our analyses thus uncovered specific programmes activated in fate-committed progenitors, including both shared ('pan-cardiac') and first-versus second heart lineage-specific signatures for heart precursors.
To characterize gene expression dynamics, we ordered singlecell transcriptomes from successive times on pseudotemporal developmental projections 23 . Using the whole dataset while ignoring established clonality, we identified multipotent progenitors and separate cardiac and pharyngeal muscle branches ( Supplementary  Fig. 4a ). However, this unsupervised analysis failed to correctly distinguish the first and second heart lineages, probably because the shared pan-cardiac programme dominates lineage-specific signatures ( Fig. 1c and Supplementary Table 2 ). Taking advantage of the invariant lineage (Fig. 1a) , we combined cells corresponding to each branch, and created three unidirectional trajectories representing first and second heart, and pharyngeal muscle lineages (Fig. 2a,b) . The distribution of cells along pseudotime axes corresponded to the times of origin ( Fig. 2c ; average Pearson correlation coefficient, PCC = 0.889), while providing higher-resolution insights into the gene expression dynamics. Validating this approach, in silico trajectories captured known lineage-specific expression changes of cardiopharyngeal regulators 18, 19, 24 (Supplementary Fig. 4c -e). Developmental trajectories suggest a continuous process marked by gradual changes in gene expression. However, the latter occur preferentially in defined 'pseudotime' windows for multiple genes (Supplementary Fig. 4c -e), consistent with more abrupt biological transitions, such as cell divisions 24 . To identify possible switch-like discontinuities, we determined cell-to-cell cross-correlations along lineage-specific trajectories. Using constrained hierarchical clustering 25 , we identified 10 putative discrete regulatory states across the cardiopharyngeal trajectories, including two multipotent states, and eight successive transitions towards fate restriction ( Fig. 2d and Supplementary Fig. 4b ).
These successive transitions revealed underlying lineage-specific transcriptional dynamics. For example, the multipotent cardiopharyngeal progenitor state (trunk ventral cell, TVC) differed markedly from subsequent cardiac states along the first cardiac trajectory (Fig. 2d,e) , and gene expression mapping distinguished 'primed' and 'de novo'-expressed heart markers, such as Gata4/5/6 and Slit1/2/3, respectively (Fig. 2f) . Conversely, primed pharyngeal muscle markers, such as Hand-r, were downregulated along cardiac trajectories, as expected 26 ( Fig. 2f and Supplementary Fig. 4c -e). Multilineage transcriptional priming is a hallmark of cardiopharyngeal multipotency, but remained to be characterized globally 19 . Here, we estimated that 41% (73/176) of the pharyngeal-muscle-specific and 53% (59/111) of the pan-cardiac markers are already expressed in multipotent progenitors, indicating that lineage-specific maintenance of primed genes is a major determinant of cell-type-specific transcriptomes in the cardiopharyngeal lineage. Nevertheless, 88% (3,504/3,982) of late-expressed transcripts were already detected in multipotent progenitors (Fig. 2g) , indicating extensive stability of the global transcriptome and thus showing that de novo cell-typespecific gene activation contributes significantly to cell-type-specific programmes (that is, the fractions of de novo expressed genes among cell-type-specific markers are greater than expected by chance, Fisher's exact test, P < 2.2 × 10 −16 for both the pan-cardiacand ASM-specific gene sets).
We further explored the molecular basis for progression through regulatory states. As a proof of concept, we first focused on the pharyngeal muscle trajectory, for which the key regulators Hand-r, Tbx1/10 and Ebf have been characterized 18, 19, 22, 24, 27 . The first two regulatory states corresponded to successive generations of multipotent cardiopharyngeal progenitors (TVCs and second trunk ventral cells, STVCs, Fig. 2d ,e), confirming that asymmetric cell divisions provide the biological basis for these first transitions (Fig. 1a) . To our surprise, the majority of newborn pharyngeal muscle precursors isolated from 16 hpf larvae clustered with multipotent progenitors isolated from 14 hpf embryos (STVCs, Fig. 2d ,e), although they were already expressing Ebf (Fig. 3a) , as previously observed using FISH 18, 24 . This indicates that, although newborn pharyngeal muscle progenitors already express a key determinant, their transcriptome remains similar to that of their multipotent mother cells. Indeed, the pharyngeal muscle transcriptome is progressively remodelled as cells transition through successive states, involving both downregulation of primed cardiac markers and de novo activation of pharyngeal muscle markers (Fig. 3a,b and Supplementary Fig. 5a ,b,d). Moreover, systematic comparison with expression profiles following perturbations of Ebf function 19 indicated that candidate Ebf target genes, including Myogenic regulatory factor (Mrf) (the MyoD/Myf5 homologue), and Myosin heavy chain 3 (Mhc3), are activated at later times, consistent with Ebf-dependent transitions to committed pharyngeal muscle states 24 ( Fig. 3a ,c-f and Supplementary Fig. 5c ).
Termination of fibroblast growth factor (FGF)-MAPK (mitogen-activated protein kinase) signalling launches a pan-cardiac programme for heart identity. Next we investigated gene expression changes underlying state transitions during cardiac specification. We focused on the first heart trajectory, which provided the largest pseudotemporal range, to characterize the pan-cardiac programme. Activation of de novo pan-cardiac markers and downregulation of primed pharyngeal muscle and multipotentspecific markers accounted for most gene expression changes ( Fig. 4a and Supplementary Fig. 5e-g ). These coordinated gene expression changes explained major transitions along the cardiac trajectories. For example, we used logistic regression to determine that Slit1/2/3 is activated at the transition between the multipotent and FHP1 states, which we confirmed by FISH ( Fig. 2f and Supplementary Fig. 2b ). We identified a principal component (principal component 1, PC1), which correlated highly with pseudotime (PCC = 0.96; Fig. 4b ), and used the PC1 loading of each gene to estimate the relative contribution of each class of markers to discrete regulatory states (Fig. 4c ). This suggested that the multipotent state is primarily determined by the combined expression of TVC-specific genes, and primed cardiac and pharyngeal muscle markers. The TVC-to-FHP1 transition is marked by a sharp decline in TVC-specific gene expression, accompanied by downregulation of primed ASM genes, upregulation of primed pan-cardiac genes and activation of de novo expressed pan-cardiac genes. In this regard, the FHP1 state may be considered a 'transition state' between a multipotent TVC state and the FHP2 state 28 . The latter is defined by the virtual absence of TVCspecific and primed ASM-specific transcripts, and high levels of both primed and de novo expressed pan-cardiac markers, thus probably corresponding to a heart-specific state, whereas activation of cell-type/lineage-specific genes underlies the FHP2-to-FHP3 transition, and their expression helps define the first heart lineage-specific state, FHP3, as is the case for Mmp21 (Fig. 4d,e) .
A true pan-cardiac programme should unfold following similar dynamics in the first and second heart lineages, reflecting shared regulatory logics. Accordingly, we observed a striking agreement between the ordered activation pattern of individual genes along each trajectory (Fig. 4f) , suggesting a remarkably conserved developmental programme. Notably, the onset of each gene was consistently delayed in the second heart trajectory, starting with the STVC-to-SHP1 transition, as SHPs are born from a second generation of multipotent progenitors, about 2 h later than FHPs (Figs. 1a  and 4f,g ). Therefore, the de novo pan-cardiac programme is tightly regulated and deployed in a reproducible cascade, whose onset is independently induced in the first and second heart lineages as they arise from multipotent progenitors. 
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We then sought to identify regulatory switches triggering the full pan-cardiac programme in heart lineages. The FGF-MAPK signalling pathway is active and maintained specifically in multipotent cardiopharyngeal progenitors (TVCs and STVCs), and in early pharyngeal muscle precursors (atrial siphon muscle founder cells, ASMFs), where it promotes the expression of Hand-r, Tbx1/10 and Ebf. By contrast, signalling is terminated in newborn FHPs and SHPs 24 . We integrated sc-and bulk RNA-seq performed on FACSpurified cardiopharyngeal-lineage cells following defined perturbations, and determined that FGF-MAPK signalling opposed pan-cardiac gene expression, while promoting the pharyngeal muscle programme in swimming larvae (18 and 20 hpf, Fig. 5a,b,  Supplementary Figs. 5h and 6a,d and Supplementary Table 6 ). At earlier stages (12 and 15 hpf), FGF-MAPK perturbations generally did not affect the expression of primed pan-cardiac genes in multipotent progenitors, whereas de novo expressed genes were upregulated on signalling inhibition by Fgfr DN misexpression (Fig. 5a,b,  Supplementary Figs. 5i ,j and 6e-h and Supplementary Table 6 ). FISH assays further demonstrated that the de novo expressed pan-cardiac marker Lrp4/8 was upregulated in TVCs on misexpression of Fgfr DN (Fig. 5c ). These analyses indicated that heart-lineage-specific termination of FGF-MAPK signalling permits the activation of de novo expressed pan-cardiac genes, and subsequent heart fate specification, whereas ongoing FGF-MAPK signalling in cardiopharyngeal progenitors promotes multipotency both by maintaining the primed pharyngeal muscle programme and by inhibiting the full deployment of the heart-specific programme (summary, Fig. 5d ).
Differences between cardiac lineages foster cellular diversity in the beating heart. A shared pan-cardiac gene programme progressively defines the heart identity, but distinct precursors nevertheless clustered separately, revealing significant differences between the first and second heart lineages ( Fig. 1b-d and Supplementary Table 2) . We mined the second heart trajectory to explore the development and evolution of the vertebrate second heart field, since the ascidian and vertebrate second heart fields share regulatory inputs from Nk4/Nkx2-5 and Tbx1/10 orthologues 8, 10, 18, [29] [30] [31] . Examining our list of markers distinguishing SHPs and FHPs, we identified the dachshund homologue Dach as the only known transcription regulator 32 ( Fig. 6a, Supplementary Fig. 3a and Supplementary Table 2), and its upregulation as cells transitioned from a multipotent state suggested a role in specifying the second cardiac identity (Fig. 6a,b) .
Dach1 and Dach2 have not previously been implicated in mammalian second heart field development, but they belong to the conserved 'retinal network' 33 , which comprises homologues of Six and Eya transcription factors that contribute to cardiopharyngeal development in the mouse 34, 35 . Lineage-specific clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated loss of function 36, 37 , followed by gene expression assays, indicated that Dach is not required either for activation of the pharyngeal muscle marker Ebf, or for its exclusion from the SHPs (Fig. 6c) . By contrast, loss of Dach function caused ectopic expression of the FHP marker Mmp21 in the SHPs (Fig. 6d) . A CRISPR-resistant Dach PAMmut complementary DNA rescued the ectopic Mmp21 expression in the second heart lineage, but did not abolish endogenous Mmp21 expression in the first heart lineage (Fig. 6d) . Dach is thus both a marker and a key regulator of second heart lineage specification, which is required, but not sufficient, to prevent activation of the first heart lineage-specific marker Mmp21.
Since the second heart lineage emerges from Tbx1/10+ multipotent progenitors 18 , we tested whether Tbx1/10 regulates Dach expression. CRISPR/Cas9-mediated lineage-specific loss of Tbx1/10 function 27 inhibited Dach expression (Fig. 6e) , and caused ectopic activation of Mmp21 (Fig. 6d) , indicating that Tbx1/10 promotes second heart lineage specification, in part by regulating Dach activation, in addition to its role in pharyngeal myogenesis.
Indeed, Tbx1/10 is also necessary in parallel to FGF-MAPK activity to activate Ebf and promote the pharyngeal muscle programme 18, 24, 27 , in a manner similar to Tbx1 function in vertebrate branchiomeric myogenesis 38, 39 . To explore the mechanism distinguishing between Tbx1/10 dual functions, we used the MAP-kinase kinase (MEK) inhibitor U0126, which inhibits Ebf expression 24 , and caused ectopic Dach activation in the lateral-most cardiopharyngeal cells that normally form Ebf + pharyngeal muscle precursors (Fig. 6f) . Moreover, Tbx1/10 misexpression and MEK inhibition synergized to cause precocious and ectopic Dach activation in cardiopharyngeal progenitors (Fig. 6g) . Taken together, these data indicate that termination of FGF-MAPK signalling in Tbx1/10 + cardiopharyngeal progenitors suffices to activate Dach expression and promote the second heart lineage identity, and demonstrate how distinct signalling environments can promote divergent regulatory programmes in concert with Tbx1/10 expression.
FHPs and SHPs share a common pan-cardiac signature, but initial molecular differences open the possibility that each lineage contributes differently to cardiogenesis. The beating Ciona heart is demonstrably simpler than its vertebrate counterpart; yet, diverse cell types form its single U-shaped compartment 40 . In post-metamorphic juveniles, the heart already beats, and double labelling with a Mesp>nls::lacZ reporter and the cardiac-specific myosin heavy chain 2 (Mhc2/Myh6) marker showed that beta-galactosidase + ;
Mhc2/Myh6
− cells surround Mhc2/Myh6 + cardiomyocytes 18, 22 . Lineage tracing using the photoconvertible reporter Kaede 19 indicated that FHP and SHP derivatives remain within largely separate domains in juvenile hearts (Fig. 7a) . Specifically, first heart lineagederived cells form the inner layer of Mhc2 + cardiomyocytes, whereas second heart lineage-derived cells contribute to the outer layer of Mhc2 − cells (Fig. 7b and Supplementary Video S1) . Triple labelling and cell quantification using pan-cardiopharyngeal and second heart lineage-specific reporters, and the Mhc2 probe, indicated that most Mhc2 + cardiomyocytes were located in the first heart lineage-derived inner layer, whereas only about 17% of second heart lineage-derived cells express Mhc2 in control juveniles (Fig. 7c) . Thus, the first and second heart lineages contribute primarily Mhc2/Myh6 + cardiomyocytes and Mhc2/Myh6 − cells to the beating juvenile heart, respectively.
To further characterize cellular diversity in the juvenile heart, we performed scRNA-seq on 386 FACS-purified cardiopharyngeal-lineage cells dissociated from stage 38 juveniles, and identified clusters corresponding to pharyngeal muscle and cardiac lineages, including Mhc2/Myh6 + cardiomyocytes and an Mhc2/Myh6 − population that expressed the second heart lineage markers Dach and Matn (Fig. 7d-f ). Triple labelling with Mesp and Tbx1/10 reporters indicated that these Dach + ;Matn + cells derived principally from the SHPs and formed the outer layer of the juvenile heart (Fig. 7g) , suggesting that cellular diversity in the beating heart emerges from the initial segregation of the first and second heart lineages. Consistent with this hypothesis, CRISPR/Cas9-mediated loss of Dach and Tbx1/10 early functions increased the proportions of Mhc2/Myh6 + cells in the SHP progeny ( Fig. 7c and Supplementary Fig. 3b ), demonstrating that early inhibition of the Mmp21 + first-lineage-specific programme by the Tbx1/10-Dach pathway limits the potential for second heart lineage derivatives to differentiate into Mhc2/Myh6 + cardiomyocytes during organogenesis.
Conserved cardiopharyngeal transcriptional signatures in chor-
dates. Finally, we asked whether molecular features of cardiopharyngeal development are shared between Ciona and vertebrates. Recent scRNA-seq analysis of early mesodermal lineages in mice identified a population of pharyngeal mesoderm marked by high levels of both Tbx1 and Dach1 expression 41 (Fig. 8a) 
, Islet1
+ cells derived from the second heart field in the outflow tract (OFT). Note the Nkx2-5
− cells in the ventricle (V). Scale bar, 100 μm. c, Aligned structure of Ciona and mouse E8.25 cardiopharyngeal cells (n = 2291 cells). t-SNE plots showing the clustering of Ciona and mouse E8.25 cardiopharyngeal cells using conserved markers determined by canonical correlation. Bar plots indicate original cell identities, defined in each species independently, as recovered in the clustering using conserved markers. d, t-SNE plots of Ciona and mouse scRNA-seq data as described in c, with the expression patterns of Ebf1 and Gata4. e, Single-cell expression profiles for the top 30 conserved markers in each species separately.
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NATure Cell BIoloGy to second heart field cells in the dorsal pericardial wall, and to a defined population of outflow tract cells, both of which also express Isl1 ( Fig. 8b and Supplementary Fig. 7 ). Dach1 expression was excluded from the Nkx2-5 + ventricle, and absent from the Isl1 + skeletal muscle progenitor cells in the core mesoderm of the first and second pharyngeal arches ( Fig. 8b and Supplementary Fig. 7 ), in a manner reminiscent of Dach exclusion from the pharyngeal muscles in Ciona (Fig. 6e,f and Supplementary Fig. 3a) . We extended the Ciona-to-mouse comparison of cardiopharyngeal transcriptomes using published scRNA-seq datasets 9, 41, 42 . We used canonical correlation analysis 43 to identify genes that separated cardiac and pharyngeal mesoderm cells in both Ciona and E8.25 mouse embryos (Fig. 8c,e and Supplementary Table 4) . We then used only the 30 best-correlated genes to recluster scRNA-seq data from each species independently, and found that these markers sufficed to distinguish cardiac and pharyngeal muscle cells in either species, revealing a shared transcriptional programme (Fig. 8c,e) . We repeated this analysis using mouse datasets from earlier embryonic stages 9, 41 , and consistently identified genes that separated cardiac and pharyngeal cells in both species, and were enriched in genes coding for transcription factors and DNA-binding proteins ( Supplementary Figs. 7c,d and 8 ). For instance, Gata4 and Ebf1 homologues were identified in all three comparisons as discriminating markers that separated cardiac and pharyngeal cells (Fig. 8c-e , Supplementary Fig. 8 and Supplementary Table 4) . Overall, this analysis suggests that an evolutionarily conserved transcriptional programme, comprising homologues of Ebf1, Gata4 and other regulatory genes, governs the heart versus pharyngeal muscle fate choice in cardiopharyngeal mesoderm.
Discussion
Here, we present an extensive analysis of the transcriptome dynamics underlying early cardiopharyngeal development in a tractable chordate model. Using established clonal relationships to inform the reconstruction of developmental trajectories, we characterized essential features of the transcriptome dynamics underlying cardiopharyngeal multipotency and early fate specification. Multipotent cardiopharyngeal progenitors exhibit extensive multilineage transcriptional priming. Together with the identification of heart-versus pharyngeal muscle-specific expression of E3 ubiquitin ligases and RNA-binding proteins, this extensive multilineage priming opens the possibility that post-transcriptional regulatory mechanisms contribute to cell-type-specific expression profiles by clearing primed gene products in a lineage-specific manner. Nevertheless, de novo gene activation significantly contributes to cell-type-specific transcriptomes, highlighting the importance of transcriptional regulation in early heart versus pharyngeal muscle fate choices.
Both first-and second heart lineage cells acquire a cardiac identity as they downregulate multipotent progenitor markers and primed pharyngeal muscle genes and deploy the full pan-cardiac programme, entering this transition state 28 on termination of FGF-MAPK signalling. We propose that the dual functions of FGF-MAPK signalling, as observed during early cardiac specification in Ciona, are conserved in vertebrates, considering that FGF-MAPK inputs are necessary to induce multipotent progenitors [44] [45] [46] , whereas signal termination is required for subsequent commitment to a heart fate and cardiomyocyte differentiation [47] [48] [49] [50] [51] . Following commitment to a cardiac identity, first heart progenitors transition to an Mmp21 + state that precedes differentiation into Mhc2/Myh6 + cardiomyocytes in the beating heart. By contrast, second heart progenitors activate Dach in response to Tbx1/10 inputs inherited from their distinct multipotent mother cells. This Tbx1/10-Dach pathway inhibits Mmp21 expression and the Mhc2/Myh6
+ cardiomyocyte potential to foster heart cell diversity. As is the case in vertebrates   30,31,38,39,52,53 , Tbx1/10 plays a dual role in branchiomeric/pharyngeal myogenesis 18, 24, 27 and second heart lineage development, thus acting as a bona fide regulator of cardiopharyngeal multipotency. Moreover, the FHPs and SHPs share a common cardiac identity but differ because they emerge from successive multipotent progenitors before and after the onset of Tbx1/10 expression. Cellular diversity in the Ciona heart thus emerges by temporal patterning, as is the case for neuronal fates in Drosophila 54 . The proposal that first and second heart lineages form a coherent cardiac developmental unit, whereas distinct lineages contribute to cellular diversity within the heart, reconciles different views about the significance of the second heart field.
Finally, by leveraging recent computational methods for crossspecies comparisons of single-cell RNA-seq datasets, we identified shared markers of cardiopharyngeal regulatory states, while highlighting differences in expression dynamics, as seen for Dach homologues, thus illustrating the plasticity of gene regulatory networks controlling conserved developmental programmes.
In conclusion, this study reveals that the first and second lineages of heart progenitors acquire a cardiac identity following the deployment of a shared and potentially ancestral programme, whereas intracardiac cell diversity emerges from specific molecular differences established in distinct multipotent progenitors for the first and second heart lineages. This model for a modular control of heart cell identity potentially reconciles prevalent but somewhat antagonistic views about the significance of heart fields in chordates.
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NATure Cell BIoloGy Methods Animals. All animal care and experiments were carried out in accord with current NIH guidelines. Ciona robusta adults were purchased from M-Rep, maintained in artificial seawater with constant illumination and used for experiment within one week of arrival. CD1 mice were crossed to generate embryos that were staged using the day of the copulation plug as embryonic day (E) 0.5.
Isolation of gametes, fertilization, dechorionation, electroporation and development. Ciona eggs and sperm were collected from at least two individual adult animals and kept separately in filtered artificial seawater (FASW) until fertilization. Eggs were mixed with activated sperm and incubated in FASW at room temperature (18-20 °C) for 5 min. Chorion and surrounding follicle cells were chemically removed with a pronase solution (FASW, 7.5 mg l −1 sodium thioglycolate, 0.05% pronase, 0.042 N NaOH), as described in ref. 56 . Fertilized and dechorionated eggs were electroporated as described in ref. 56 , and cultured in FASW in agarose-coated plastic Petri dishes at 18 °C. The amount of fluorescent reporter DNA (Mesp>nls::lacZ, Mesp>hCD4::mCherry, Mesp>tagRFP, MyoD905>EGFP and Hand-r>tagBFP) for electroporation was typically 50 µg, but that of Tbx1/10 3XT12 >H2B::mCherry was 30 µg. To increase the survival rate of juveniles, healthy and fluorescent-positive larvae were selected at FABA stage 26/27 using Leica M205 FA fluorescence stereo microscopes and transferred to uncoated Petri dishes with fresh FASW. The larvae were cultured at 18 °C until collection.
Dissociation and FACS.
Sample dissociation and FACS were performed essentially as described in refs. 19, 56, 57 . Embryos and larvae were collected at 12, 14, 16, 18 and 20 hpf in 5 ml borosilicate glass tubes (Fisher Scientific, catalogue no. 14-961-26) and washed with 2 ml calcium-and magnesium-free artificial seawater (CMF-ASW: 449 mM NaCl, 33 mM Na 2 SO4, 9 mM KCl, 2.15 mM NaHCO 3 , 10 mM Tris-Cl at pH 8.2, 2.5 mM EGTA). The tunique of juveniles was peeled off using BD PrecisionGlide needles (reference 305115) under the dissecting microscope to facilitate dissociation. Embryos and larvae were dissociated in 2 ml 0.2% trypsin (w/v, Sigma, T-4799) CMF-ASW by pipetting with glass Pasteur pipettes. The dissociation was stopped by adding 2 ml filtered ice-cold 0.05% BSA CMF-ASW. Dissociated cells were passed through a 40 µm cell-strainer and collected in 5 ml polystyrene round-bottom tubes (Corning Life Sciences, ref 352235). Cells were collected by centrifugation at 800 g for 3 min at 4 °C, followed by two washes with ice-cold 0.05% BSA CMF-ASW. Cell suspensions were filtered again through a 40 µm cell-strainer and stored on ice. Following dissociation, cell suspensions were used for sorting within 1 h. B7.5 lineage cells were labelled with a Mesp>tagRFP reporter. Contaminating B-line mesenchyme cells were counter-selected using MyoD905>EGFP as described in refs. 18, 19, 56 . The TVC-specific Hand-r>tagBFP reporter was used in a three-colour FACS scheme for positive co-selection of TVC-derived cells, to minimize the effects of mosaicism. Dissociated cells were loaded in a BD FACS Aria cell sorter 57 . A 488 nm laser and fluorescein isothiocyanate filter were used for enhanced green fluorescent protein (EGFP); a 407 nm laser, 561 nm laser and DsRed filter were used for tagRFP (red fluorescent protein) and a Pacific BlueTM filter was used for tagBFP (blue fluorescent protein). The nozzle size was 100 µm. tagRFP + , tagBFP + and EGFP -cells were collected for downstream RNA sequencing analysis.
FISH-immunohistochemistry in
Ciona larvae. FISH-immunohistochemistry was performed essentially as described in refs. 18, 19, 56 . Embryos were collected and fixed at desired developmental stages for 2 h in 4% MEM-PFA (paraformaldehyde) and stored in 75% ethanol at −20 °C. Antisense RNA probes were synthesized using either Gateway gene collections or amplified fragments of desired genes as templates (Supplementary Table 3 ). In vitro antisense RNA synthesis was performed using T7 RNA polymerase (Roche, catalogue no. 10881767001) and DIG RNA labelling mix (Roche, catalogue no. 11277073910). An anti-digoxigenin-POD Fab fragment (Roche) was first used to detect the hybridized probes, then the signal was revealed using tyramide signal amplification with Fluorescein TSA Plus kits (Perkin Elmer). Anti-β-galactosidase monoclonal mouse antibody (Promega) was co-incubated with anti-mCherry polyclonal rabbit antibody (Bio Vision, catalogue no. 5993-100) for immunodetection of Mesp>nls::lacZ and Mesp>hCD4::mCherry products respectively. Goat anti-mouse secondary antibodies coupled with AlexaFluor-555 and AlexaFluor-633 were used to detect β-galactosidase-bound mouse antibodies and mCherry-bound rabbit antibodies after the tyramide signal amplification reaction. FISH samples were mounted in ProLong gold antifade mountant (ThermoFisher Scientific, catalogue no. P36930).
Multicolour immunohistochemical staining in mouse embryo. After dissection, embryos were fixed for 30 min (E8.5 and E9.5) to 1 h (E7.5 in decidua) in 4% PFA, dehydrated and embedded in paraffin before sectioning at 10 µm. Immunofluorescence was performed using standard protocols. Briefly, after rehydration, sections were treated for 15 min with antigen unmasking solution (H-3300, Vector Laboratories). Slides were washed twice in 1 × PBS Tween (0.05%) and incubated for 1 h in TNB buffer (0.1 M Tris-HCl at pH 7.5, 0.15 M NaCl, 0.5% blocking reagent (Roche 11096176001)). Sections were incubated with primary antibodies for 36 h in TNB using the following dilutions: Dach1, 1/100 (Proteintech 10914
.05%), sections were incubated with secondary antibodies for 1 h using Alexa 488, 568 and 647 (1/500, Invitrogen). Sections were counterstained with Hoechst (Sigma 33258), mounted using Fluoromount (Southern Biotech 0100-001) and imaged using a Zeiss Axio Imager Z1 with an Apotome module.
CRISPR/Cas9-mediated gene knockdown. Two guide RNAs targeting the third and the fifth exon of Dach with Fusi scores (http://crispor.tefor.net) 63 (sgDach1, AAAAGATTAAGCATCGCCC) and 64 (sgDach2, GAGCATTGCCATTGACGTG), respectively, were designed to mutagenize the Dach locus in the B7.5 lineage using CRISPR/Cas9 as described in ref. 37 . Two guide RNAs described by Tolkin and Christiaen 27 (sgTbx1.6, TGCGGCTTCGGCTCCGTGG; sgTbx1.8, AACGAAAGATTGGTGGCCG), were used to mutagenize the Tbx1/10 coding region. The efficiencies of guide RNAs were evaluated using the peakshift method 37 . Guide RNAs were expressed using the C. robusta U6 promoter 36 . For each gene, two guide RNAs were used in combination with 25 µg of each expression plasmid. Mesp>nls::Cas9::nls plasmid (30 µg) was co-electroporated with guide RNA expression plasmids for B7.5 lineage-specific CRISPR/Cas9-mediated mutagenesis. Rescue of the Dach loss of function was achieved by TVC-specific overexpression of Dach PAMmut driven by a Foxf enhancer 58 . Point mutations (G303A and C852A) were introduced into the protospacer adjacent motifs of sgDach1 and sgDach2 using an optimized QuikChange site-directed mutagenesis protocol. Two pairs of mutagenesis primers were designed using the PrimerX website (http:// www.bioinformatics.org/primerx/cgi-bin/DNA_1.cgi): sgDACH_1_G303A_F, GATTAAGCATCGCCCCAGTCGTGTGCAACGTTG; sgDACH_1_G303A_R, CAACGTTGCACACGACTGGGGCGATGCTTAATC; and sgDACH_2_ C852A_F, CGTCGGGAATTCCACCCACGTCAATG; sgDACH_2_C852A_R, CATTGACGTGGGTGGAATTCCCGACG. The PCR mixture was prepared as 20 µl 5 × HF buffer, 71 µl H 2 O, 3 µl 10 mM deoxynucleotide triphosphate (dNTP), 1.75 µl wild-type Dach plasmid at 15 ng µl −1 , 2 µl 125 ng µl −1 top mutagenesis primer, 2 µl 125 ng µl −1 bottom mutagenesis primer and 1 µl Phusion High-Fidelity DNA polymerase (NEB M0530). PCR mixture was evenly distributed into eight PCR tube-strips and PCR was performed with a denaturation at 95 °C for 4 min, followed by 18 cycles of (95 °C for 30 s, 50 to 72 °C (gradient) for 1 min, and 72 °C for 1 min) and a final extension at 72 °C for 5 min. The PCR products were pooled and 4 µl of DpnI was added directly to the tube, followed by incubation at 37 °C for 2 h. After purification using a QIAquick PCR purification kit (QIAGEN), the eluates were transformed into TOP10 cells. Successful mutagenesis was confirmed by sequencing.
Photoconversion and lineage tracing. Photoconversion and lineage tracing were performed as described in ref. 19 . Fertilized eggs were electroporated with 50 µg Mesp>Kaede:nls to label the B7.5 lineage. Embryos were raised on agarose-coated plastic Petri dishes in ASW at 18 °C and transferred individually into Nunc MicroWell 96-well optical-bottom plates (ThermoFisher Scientific, supplier no. 164588) at 15 hpf. Photoconversions were performed using an HC PL FLUOTAR ×20/0.50 objective on a Leica Microsystems inverted TCS SP8 X confocal microscope, by shining 405 nm ultraviolet light on the region of interest continuously for 2 min. Stack scanning of the whole TVC lineage was documented at 16, 22.5, 40, 48 and 65 hpf.
Confocal microscopy. Images were acquired with an inverted Leica TCS SP8 X confocal microscope, using an HC PL APO ×63/1.30 objective. Z-stacks were acquired with 1 µm Z-steps. Maximum projections were processed with maximum projection tools from the Leica software LAS-AF.
Image processing and quantification. Confocal microscopy Z-stacks were processed using Imaris x64 8.4.1 (BitPlane). A region containing the TVC progeny was segmented first. For nucleus detection, the expected nucleus diameter was set at 2.5 µm; Nucleus Threshold(Absolute Intensity) was calculated automatically by Imaris. The cell segmentation was carried out using the 'Detect Cell Boundary from Cell Membrane' function; the 'Cell Smallest Diameter' was set as 5 µm. The transcript signal within the cell boundary was detected using the 'Vesicles Detection' function; the estimated diameter of dots was set as 1.44 µm. To count the number of Mhc2 + , Matn + or Dach + cells in the juvenile heart, a region of juvenile heart was segmented first, then the nucleus detection was performed as described above. A surface was created from the channel of FISH detention. Then the 'Find Spots Close To Surface' function was used to define the nucleus with transcripts (the surface) close to it using a 2 µm threshold.
Bulk RNA-seq library preparation, sequencing and analyses. Between 200 and 800 cells were directly sorted in 100 µl lysis buffer from an RNAqueous-Micro total RNA isolation kit (Ambion). For each condition, samples were obtained in biological duplicates. The total RNA extraction was performed following the manufacturer's instructions. The quality and quantity of total RNA were checked using an Agilent RNA 6000 Pico kit (Agilent) with an Agilent 2100 Bioanalyzer. RNA samples with RNA integrity number greater than 8 were kept for downstream cDNA synthesis. Total RNA (250-2000 pg) was loaded as a template for cDNA synthesis using a SMART-Seq v4 Ultra Low Input RNA kit (Clontech) with template switching technology. RNA-Seq Libraries were prepared and barcoded using Ovation Ultralow System V2 1-16 (NuGen). Up to six barcoded samples were pooled in one lane of the flow cell and sequenced with an Illumina HiSeq 2500. One direction and 50-bp (base pair) length reads were obtained from all the bulk RNA-seq libraries.
Sequencing reads were mapped to the C. robusta genome (joined scaffold (KH), http://ghost.zool.kyoto-u.ac.jp/datas/JoinedScaffold.zip) using TopHat 2.0.12 (refs. 59, 60 ) with parameter -no-coverage-search. Cufflinks 2.2.0 (ref. 60 ) was used to calculate the FPKM. We used edgeR (ref. 61 ) to analyse differential gene expression in pairwise comparisons. Detailed summary statistics are provided in Supplementary Table 6 .
Single-cell RNA-seq library preparation and sequencing. Reverse transcription and cDNA amplification were carried out using a modified Smart-seq2 protocol 20 . Single cells were sorted by FACS as described above into 96-well plates and collected in 3.4 µl reverse transcription buffer (0.5 µL 10 µM 3′ reverse transcription primer (5′-AAG CAG TGG TAT CAA CGC AGA GTA C T30 VN-3′), 0.5 µl 10 µM deoxynucleotide triphosphate mix, 0.5 µl 4 U µl −1 RNase inhibitor, 1 µl Maxima RT buffer, 0.9 µl nuclease-free water) in each well. Plates were either stored at −80 °C or processed immediately. Plates were incubated at 72 °C for 3 min and chilled on ice to denature the template RNA. Reverse transcription reaction mixture (2 µl: 0.5 µl 10 µM TSO primer (5′-AGACGTGTGCTCTTCCGATCTNNNNNrGrGrG-3′), 0.925 µl 5 M betaine, 0.4 µl 100 mM MgCl 2 , 0.125 µl 40 U µl −1 RNase inhibitor, 0.05 µl 200 U µl −1 Maxima H Minus reverse transcriptase) were added to each well. Reverse transcription was carried out by incubating the plate at 42 °C for 90 min, followed by 10 cycles of (50 °C for 2 min, 42 °C for 2 min) and heat inactivation at 70 °C for 15 min. 7 µl PCR amplification mixture (0.25 µl 10 μM PCR primer (5′-AGACGTGTGCTCTTCCGATCT-3′), 6.25 µl KAPA HIFI ReadyMix, 0.5 µl nuclease-free water) were added to each well. PCR amplification was carried out with a denaturation at 98 °C for 3 min, followed by 21 cycles of (98 °C for 15 s, 67 °C for 20 s and 72 °C for 6 min) and a final extension at 72 °C for 5 min. PCR products were purified by adding 10 µl (0.8×) Agencourt AMPureXP SPRI beads (BeckmanCoulter) to each well, followed by 5 min incubation and two washes with 100 µl freshly prepared 70% ethanol at room temperature. Purified cDNA was eluted in 20 µl TE buffer. The concentration of amplified cDNA was measured across the entire plate using Picogreen assays. The concentration of amplified cDNA was in a 0.5-2 ng μl −1 range. Fragment size distributions were checked for randomly selected wells with a High-Sensitivity Bioanalyzer Chip (Agilent); the expected size average should be about 2 kilobases. For each sample, the amplified cDNA was normalized to a working concentration ranging from 0.1 to 0.2 ng µl −1 with TE buffer. 1.25 µl of diluted cDNA from each well was used for library preparation. Single-cell libraries were prepared using a Nextera XT DNA sample kit (Illumina) according to the manufacturer's instructions. After library amplification, 2.5 μl from each well was pooled into a single 1.5 ml microcentrifuge tube, purified using Agencourt AMPure XP beads and eluted with 30 μl of TE buffer. The purified library (1 μl) was used to measure the fragment size distribution with an Agilent HS DNA BioAnalyzer chip and another 1 μl of the purified library was loaded into a Qubit fluorometer to estimate library concentration according to the manufacturer's instructions. Libraries were sequenced on an Illumina HiSeq 2500 sequencer to obtain paired-end 50-bp reads.
Quantification and statistical analysis. Read alignment and generation of gene expression matrix. For each demultiplexed bulk and single-cell RNA-seq library, sequencing reads were mapped to the C. robusta genome (joined-scaffold (KH), http://ghost.zool.kyoto-u.ac.jp/datas/JoinedScaffold.zip) using TopHat 2.0.12 (refs. 59, 60 ) with parameter -no-coverage-search. Cufflinks 2.2.0 (ref. 60 ) was used to calculate the FPKM.
Preprocessing and batch effect removal. We adopted multiple quality control criteria to filter out low-quality single-cell transcriptomes. First, we only retained single cells that had more than 2,000 and fewer than 6,000 expressed genes, and genes that were detected in more than three cells. Totals of 1,182 out of 1,796 single cells and 14,864 out of 15,287 genes were retained. We used total reads and overall read mapping rates from TopHat output files to assess the quality of scRNA-seq. Cells with mapping rates less than 30% and total reads more than 2 million were removed (Supplementary Note). Of the 1,182 cells, 1,138 passed the quality controls and were retained for downstream analyses.
Batch effects were identified by principal component analysis (PCA) using all detected genes. Principal components 2, 5 and 7 were dominated by either ribosomal genes or unannotated genes that showed strong expressions only in certain batches (Supplementary Note). These PCs were considered as batch effects created by sequencing and library preparation. For each gene j, its expression level Identification of variable genes and dimensional reduction analysis. All scRNA-seq analyses were performed on the data for each time individually. Downstream analysis followed the procedures of the Seurat R package v1.2 (ref. 21 ; http:// satijalab.org/seurat).
We first identified the set of genes that was most variable in 12, 14 and 20 hpf single-cell data. We calculated the mean and dispersion (variance/mean) for each gene across all single cells, and placed genes into 20 bins on the basis of their average expression. Within each bin, we then Z-normalized the dispersion measure of all genes within the bin to identify genes whose expression values were highly variable even when compared with genes with similar average expressions. We used a Z-score cutoff of 2 for dispersion and an average expression cutoff of 4 log(FPKM) to identify highly variable genes. We then used these highly variable genes as input to the PCA to identify the primary data structures in 12, 14 and 20 hpf data. For intermediate stages, 16 hpf and 18 hpf, because of the known celltype similarity, we used cell-type-specific markers from 14 hpf and 20 hpf as input to the PCA to obtain more robust dimensional reduction.
We extended the results of PCA analysis globally by projecting the PCA rotation matrix across the entire transcriptome. This additional projection allows us to identify other genes with strong PCA loadings that may not be included in our variable gene list. Statistically significant PCs were identified using a permutation test and independently confirmed using a modified resampling procedure 62 encoded in Seurat's 'jackStraw' function. Significant and biological meaningful PCs were retained for clustering and visualization. To visualize singlecell data, we projected individual cells on the basis of their PC scores onto a single two-dimensional map using t-SNE (ref. 63 ).
Single-cell clustering and differential gene expression. Clustering of single cells was performed using the weighted shared nearest-neighbour graph-based clustering method 64 . To validate the legitimacy of the clusters, we used the 'ValidateClusters' function in Seurat, where we selected the top 30 genes from significant PCs as defined above and utilized them to build a linear kernel support vector machine. The predictive accuracy of the support vector machine was assessed by repeated fivefold cross-validation. Accuracy cutoffs of 0.8 and 0.85 were used, and the merging of clusters was done based on the minimal connectivity from the shared nearest-neighbour graph with a threshold of 0.001. Subsequently, TVC, STVC, FHP, SHP and ASM cells were identified from data for each time based on both known and candidate markers (Supplementary Table 2 ). Specifically, for 12 hpf data, no significant PC was identified due to the small and homogeneous TVC population. In 18 hpf data, we also identified a cluster of 33 cells that expressed noticeable degrees of both cardiac and ASM markers (Supplementary Notet). We inferred that this cluster of cells is possibly due to insufficient tissue dissociation or to sorting and sequencing errors. We removed these cells from further analysis.
The dataset can be mined through an online tool (ShinyApp) available at https://christiaenlab.shinyapps.io/tvc-lineage/ (for example test using the pancardiac and ASM markers GATA4/5/6 and EBF1/2/3/4).
To find markers differentially expressed among clusters, we used the same approach as in ref. 65 . We used the binary classifier with the receiver operating characteristic curve that was incorporated in Seurat's 'find.markers' function with parameters test.use = 'roc' , thresh.use = 1 and min.pct = 0.5, which selects genes that are expressed in more than 50% of single cells in the given cluster and with average expression larger than log 2 (FPKM) for differential expression analysis. The selected genes were ranked based on areas under the curve from 0 to 1. The higher the area under the curve or power value the more differentially expressed the gene is for the given cluster. Areas under the curve of 0.5 or below have limited predictive power.
Single-cell trajectory and transition state. We retrieved scRNA-seq data for each of the FHP, SHP and ASM trajectories by subsetting the master Seurat object containing all the single-cell data. We applied diffusion maps 66, 67 for non-linear dimensional reduction in order to identify developmental trajectories. We used the markers (power > 0.3) of all cell types in each trajectory to calculate a cell-to-cell pairwise Euclidean distance matrix and used this matrix as input to the diffusion map ('diffuse' function from 'diffusionMap' package). We retained only the first two diffusion map components as the developmental trajectory for pseudotime analysis. Every cell was assigned to a pseudotime coordinate by fitting a principal curve 68 to the first two diffusion map components. Pseudotime was determined by the unit-speed arc-length parameterization of each cell on the principal curve and normalized to the [0,1] range.
After identification of the pseudotime, we selected genes that are dynamically expressed across pseudotime using the 'aic' function in the 'locfit' package. Genes expressed in more than 50% of single cells with mean expression level greater than 2 log(FPKM) were considered as expressed in each cell type. For every expressed gene, we built two local polynomial models: a null model with degree 0 that 1 nature research | reporting summary The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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